Psychedelic psilocybin in magic mushrooms outperformed leading depression treatment
stokesentinel.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from stokesentinel.co.uk Daily Mail and Mail on Sunday newspapers.
Psychedelic psilocybin in magic mushrooms outperformed leading depression treatment
cambridge-news.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cambridge-news.co.uk Daily Mail and Mail on Sunday newspapers.
The psychedelic compound found in magic mushrooms may be at least as effective as a leading antidepressant medication in a therapeutic setting, a new study suggests.
Researchers compared the therapeutic potential of psilocybin – found in the mushrooms – with a six-week course of the antidepressant escitalopram in 59 people with moderate to severe depression.
They found that, while depression scores were reduced in both groups, the reductions occurred more quickly in the psilocybin group and were greater in magnitude.
However, they warned that the main comparison between psilocybin and the antidepressant was not statistically significant.
They said larger trials with more patients over a longer period are needed to show if the compound can perform as well as, or more effectively than, an established antidepressant.
Psychedelic psilocybin in magic mushrooms outperformed leading depression treatment
Psilocybin appeared to treat depression more quickly, for longer and with few side effects than antidepressant escitalopram.
Updated
Subscribe
When you subscribe we will use the information you provide to send you these newsletters. Your information will be used in accordance with ourPrivacy Notice.
Thank you for subscribingWe have more newslettersShow meSee ourprivacy notice
The psychedelic drug found in magic mushrooms has outperformed one of the leading treatments for depression during a scientific study.
The research suggested it may be at least as effective as a leading antidepressant medication in a therapeutic setting,